Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,773.50
Bid: 1,772.00
Ask: 1,772.50
Change: 12.50 (0.71%)
Spread: 0.50 (0.028%)
Open: 1,770.00
High: 1,776.00
Low: 1,766.00
Prev. Close: 1,761.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Energy, healthcare stocks lift FTSE 100; BHP Group shines

Tue, 17th Aug 2021 09:46

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* UK employment closer to pre-pandemic levels

* BHP Group jumps on strong results

* PLUS500 gains on robust revenue forecasts

* FTSE 100 up 0.3%, FTSE 250 off 0.2%
(Updates to close)

By Shashank Nayar and Amal S

Aug 17 (Reuters) - London's FTSE 100 rose on Tuesday, helped
by gains in heavyweight energy and healthcare stocks, with
sentiment bolstered by robust earnings from BHP Group and
employment numbers that showed a steady economic recovery in the
UK.

After falling as much as 0.5%, the blue-chip FTSE 100 index
ended 0.3% higher, helped by oil majors BP and
Royal Dutch Shell as crude prices recouped early
losses.

Healthcare stocks rose 1.1% with drugmakers
including AstraZeneca, GlaxoSmithKline, and
Hikma Pharmaceuticals rising between 1% and 2.3%.

Miner BHP Group gained 3.1% to the top of the FTSE
100 after posting its best annual profit in nearly a decade. It
also announced an exit from its $13 billion petroleum business
in a portfolio shake-up that will see it leave London's FTSE 100
index.

"BHP has a clear strategy now of focusing on future-proofed
commodities which are part of the transition away from fossil
fuels or in other words being part of the solution rather than
part of the problem and it's an approach which is winning favour
from the market," said Russ Mould, investment director at AJ
Bell.

Steadily rising commodity prices and cheap interest rates
have helped the FTSE 100 rise nearly 11% year-to-date, but
inflation pressure, risks linked to the coronavirus pandemic and
less weightage of tech stocks on the index have led it to
underperform developed-market peers.

The number of employees on British company payrolls rose by
182,000 in July from June, moving closer to their pre-pandemic
level as the economy recovers from its coronavirus lockdowns,
tax data showed.

Unemployment in the UK dropped to 4.7% in the three months
to June, lower than economist expectations of 4.8%.

The domestically focussed mid-cap index eased 0.2%,
with travel stocks declining the most.

Online trading platform Plus500 jumped 5.1% to the
top of the mid-cap index after it forecast annual revenue
"significantly ahead" of analysts' estimates.

UK-listed shares of food-ordering firm Just Eat Takeaway.com
gained 2.9% and was the second-best performer on FTSE
100, after it reported a better-than-expected operating loss of
190 million euros ($224 million) for the first half of
2021.
(Reporting by Shashank Nayar and Amal S in Bengaluru; Editing
by Subhranshu Sahu and Uttaresh.V and Bernadette Baum)

More News
12 Feb 2024 17:11

London close: Stocks finish higher after very quiet Monday

(Sharecast News) - London markets managed modest gains by the close of a subdued trading session on Monday, with no significant corporate or economic catalysts driving movements.

Read more
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.